THERANEXUS PUBLISHES ITS 2022 FULL-YEAR RESULTS AND PRESENTS AN UPDATE ON ITS PROGRAMS

Lyon, France - 12 April 2023 - 6pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases and pioneer in the development of drug candidates modulating

Related Keywords

United States ,Chicago ,Illinois ,Paris ,France General ,France ,French ,Florence Portejoie ,Thierry Lambert ,Worldsymposium Orlando ,Martin Pierre Laurent ,Marco Sardiello ,Mathieu Charv ,Emyr Lloyd Evans ,Inserm Transfert ,Claude Bernard Lyon ,Cardiff University United Kingdom ,Research Association ,Twitter ,French National Institute Of Health ,Research Tax Credit ,Federation Of European Neurosciences Societies ,Research Inserm ,Atomic Energy Commission ,Translational Research Conference For The Management ,Baylor College Of Medicine Houston ,Franck Mouthon ,European Neurosciences Societies ,Batten Disease Support ,Healthcare Conference ,Baylor College ,Cardiff University ,United Kingdom ,Research Conference ,French National Institute ,Medical Research ,Hospices Civils De Lyon ,French Alternative Energies ,Euronext Growth ,Theranexus ,Ublishes ,022 ,Bull ,Ear ,Results ,Presents ,Update ,Programs ,